We are live on ! Find out more
SCMP

Sucampo Pharmaceuticals, Inc.
SCMP

Delisted

SCMP was delisted on the 12th of February, 2018.

167 hedge funds and large institutions have $287M invested in Sucampo Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 57 increasing their positions, 47 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 30

32% more call options, than puts

Call options by funds: $1.48M | Put options by funds: $1.12M

21% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 47

1% more funds holding

Funds holding: 165167 (+2)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

16% less capital invested

Capital invested by funds: $340M → $287M (-$52.9M)

Holders
167
Holders Change
+2
Holders Change %
+1.21%
% of All Funds
4.16%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
40
Increased
57
Reduced
47
Closed
30
Calls
$1.48M
Puts
$1.12M
Net Calls
+$359K
Net Calls Change
+$1.1M
Name Holding Trade Value Shares
Change
Change in
Stake
California Public Employees Retirement System
126
California Public Employees Retirement System
California
$130K -$34.8K -3,000 -20%
SG Americas Securities
127
SG Americas Securities
New York
$125K -$157K -13,520 -54%
DekaBank Deutsche Girozentrale
128
DekaBank Deutsche Girozentrale
Germany
$123K -$10.4K -900 -8%
VOYA Investment Management
129
VOYA Investment Management
Georgia
$120K
AG
130
Aperio Group
California
$119K +$125K +10,793 New
SGAM
131
Smith Group Asset Management
Texas
$117K
T. Rowe Price Associates
132
T. Rowe Price Associates
Maryland
$115K
LSERS
133
Louisiana State Employees Retirement System
Louisiana
$111K +$117K +10,100 New
AIM
134
Acrospire Investment Management
Illinois
$104K -$176K -15,174 -62%
Public Employees Retirement Association of Colorado
135
Public Employees Retirement Association of Colorado
Colorado
$92K
BNP Paribas Financial Markets
136
BNP Paribas Financial Markets
France
$90.4K +$39.1K +3,368 +69%
TRSOTSOK
137
Teachers Retirement System of the State of Kentucky
Kentucky
$88K +$92.9K +8,000 New
AG
138
Advisor Group
Arizona
$87K +$19.8K +1,704 +27%
BAM
139
Barrett Asset Management
New York
$86K
Lazard Asset Management
140
Lazard Asset Management
New York
$77K
MSA
141
Mason Street Advisors
Wisconsin
$64K +$67.2K +5,788 New
MERSOM
142
Municipal Employees' Retirement System of Michigan
Michigan
$62K +$65.5K +5,640 New
PNC Financial Services Group
143
PNC Financial Services Group
Pennsylvania
$47K +$720 +62 +1%
SEI Investments
144
SEI Investments
Pennsylvania
$35K +$17.7K +1,525 +94%
PI
145
PineBridge Investments
New York
$35K +$37.5K +3,229 New
CTC
146
Central Trust Company
Missouri
$34K +$30.9K +2,661 +605%
Simplex Trading
147
Simplex Trading
Illinois
$32K +$34.3K +2,957 New
QT
148
Quantbot Technologies
New York
$29K +$31K +2,673 New
SOADOR
149
State of Alaska Department of Revenue
Alaska
$29K +$31.2K +2,690 New
LTFS
150
Ladenburg Thalmann Financial Services
Florida
$24K +$7.15K +616 +38%

SCMP Hedge Fund Activity: Q1 2017 in Review

167 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Sucampo Pharmaceuticals, Inc. (SCMP) for Q1 2017, worth a combined $287M — down 16% from $340M a quarter earlier.

Buyers outnumbered sellers: 40 funds opened new SCMP positions and 30 closed out — a net gain of 10 holders — while 57 added to existing stakes and 47 trimmed.

The largest buyer was BlackRock, adding an estimated $41.4M. The largest seller was UBS O'Connor, exiting entirely with an estimated $6.78M sold.

  • 167 institutional investors held Sucampo Pharmaceuticals, Inc. (SCMP) as of Q1 2017, up from 165 in Q4 2016.
  • Funds reported $287M of Sucampo Pharmaceuticals, Inc. stock for Q1 2017, down 16% quarter-over-quarter.
  • 40 funds opened new Sucampo Pharmaceuticals, Inc. positions in Q1 2017 and 30 closed out, a net change of +10 holders.
  • The largest Sucampo Pharmaceuticals, Inc. buyer in Q1 2017 was BlackRock, an estimated $41.4M added.
  • The largest Sucampo Pharmaceuticals, Inc. seller in Q1 2017 was UBS O'Connor, an estimated $6.78M sold.

Based on aggregated 13F filings for Q1 2017.